RILs standalone 3QFY17 EBITDA was below estimates at Rs 106bn ( 4% YoY) led by lower GRM and muted petchem demand. Domestic petchem demand was weak on account of demonetisation. This resulted in higher exports with lower margins. The higher other income boosted APAT to Rs 80bn.